Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
NRX Pharmaceuticals ( (NRXP) ) has provided an update.
On January 7, 2025, Janet Rehnquist resigned from the Board of Directors of NRx Pharmaceuticals, effective immediately, without any disagreements with the company’s operations, policies, or practices. Her resignation follows the approval of a term sheet with JGS Holdings LLC, granting Sauer Nunes the right to nominate a new board member, with management currently reviewing nominees.
More about NRX Pharmaceuticals
YTD Price Performance: 64.21%
Average Trading Volume: 1,006,308
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $58.66M
See more data about NRXP stock on TipRanks’ Stock Analysis page.
